Skip to main content
Erschienen in: Tumor Biology 5/2012

01.10.2012 | Research Article

Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells

verfasst von: Qingchang Li, Hui Gao, Hongtao Xu, Xin Wang, Yongqi Pan, Fengxia Hao, Xueshan Qiu, Maggie Stoecker, Endi Wang, Enhua Wang

Erschienen in: Tumor Biology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Ezrin, one of the ezrin–radixin–moesin proteins, is involved in the formation of cell membrane processes such as lamellipodia and filopodia and acts as a membrane–cytoskeleton linker. Its aberrant expression correlates with development and progression of several human cancers. However, the expression of ezrin and its role in lung cancer are currently unknown. In this study, we performed ezrin small interfering RNA transfection in two lung cancer cell lines and examined the effects on malignant phenotypes in cancer cells by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, wound healing, and chamber transwell assays. Ezrin knockdown significantly reduced the proliferation, migration, and invasion of lung cancer cells in vitro. To address the possible mechanisms, we evaluated the expression of adhesion molecules E-cadherin and β-catenin by Western blot and reverse transcriptase-polymerase chain reaction analyses. The results demonstrated that downregulation of ezrin reduced β-catenin and increased E-cadherin at the protein level but had no effects on their mRNA levels, suggesting posttranscriptional regulation of these two adhesion molecules. Immunofluorescence assays revealed that ezrin knockdown restored membranous expression of E-cadherin and decreased cytoplasmic β-catenin in lung cancer cells. In addition, ezrin expression was immunohistochemically evaluated on 135 normal and 183 lung cancer tissues. The expression of ezrin was significantly higher in cancer samples than paired autologous normal lung tissues. In normal bronchial epithelium, ezrin was mainly localized on the apical membrane, while in lung cancers and metastatic foci, ezrin was primarily distributed in cytoplasm. Among lung cancer tissues, expression of ezrin was higher in the invasive front of primary lesions and the highest in lymphatic metastasis. Statistical analysis demonstrated that ezrin expression correlated significantly with lymphatic metastasis and advanced TNM stage. Our data suggest that ezrin may play a crucial role in governing the biological behavior of lung cancer.
Literatur
1.
Zurück zum Zitat Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol. 2008;3:6–12.CrossRefPubMed Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol. 2008;3:6–12.CrossRefPubMed
2.
Zurück zum Zitat Shibue T, Weinberg RA. Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Semin Cancer Biol. 2011;21:99–106.CrossRefPubMed Shibue T, Weinberg RA. Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Semin Cancer Biol. 2011;21:99–106.CrossRefPubMed
3.
Zurück zum Zitat Lallemand D, Arpin M. Moesin/ezrin: a specific role in cell metastasis? Pigm Cell Melanoma R. 2010;23:6–7.CrossRef Lallemand D, Arpin M. Moesin/ezrin: a specific role in cell metastasis? Pigm Cell Melanoma R. 2010;23:6–7.CrossRef
4.
Zurück zum Zitat Neisch AL, Fehon RG. Ezrin, Radixin and Moesin: key regulators of membrane–cortex interactions and signaling. Curr Opin Cell Biol. 2011;23:377–82.CrossRefPubMedPubMedCentral Neisch AL, Fehon RG. Ezrin, Radixin and Moesin: key regulators of membrane–cortex interactions and signaling. Curr Opin Cell Biol. 2011;23:377–82.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Huang HY, Li CF, Fang FM, Tsai JW, Li SH, Lee YT, et al. Prognostic implication of ezrin overexpression in myxofibrosarcomas. Ann Surg Oncol. 2010;17:3212–9.CrossRefPubMed Huang HY, Li CF, Fang FM, Tsai JW, Li SH, Lee YT, et al. Prognostic implication of ezrin overexpression in myxofibrosarcomas. Ann Surg Oncol. 2010;17:3212–9.CrossRefPubMed
6.
Zurück zum Zitat Xie JJ, Xu LY, Xie YM, Zhang HH, Cai WJ, Zhou F, et al. Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Int J Cancer. 2009;124:2549–58.CrossRefPubMed Xie JJ, Xu LY, Xie YM, Zhang HH, Cai WJ, Zhou F, et al. Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Int J Cancer. 2009;124:2549–58.CrossRefPubMed
7.
Zurück zum Zitat Ohtani K, Sakamoto H, Rutherford T, Chen Z, Kikuchi A, Yamamoto T, et al. Ezrin, a membrane–cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett. 2002;179:79–86.CrossRefPubMed Ohtani K, Sakamoto H, Rutherford T, Chen Z, Kikuchi A, Yamamoto T, et al. Ezrin, a membrane–cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett. 2002;179:79–86.CrossRefPubMed
8.
Zurück zum Zitat Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, et al. The membrane–cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 2004;10:182–6.CrossRefPubMed Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, et al. The membrane–cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 2004;10:182–6.CrossRefPubMed
9.
Zurück zum Zitat Ana C, Bendahl PO, Åkerman M, Domanski HA, Rydholm A, Engellau J, et al. Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas. J Clin Pathol. 2011;64:689–94.CrossRef Ana C, Bendahl PO, Åkerman M, Domanski HA, Rydholm A, Engellau J, et al. Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas. J Clin Pathol. 2011;64:689–94.CrossRef
10.
11.
Zurück zum Zitat Kocher HM, Sandle J, Mirza TA, Li NF, Hart IR. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Gut. 2009;58:271–84.CrossRefPubMed Kocher HM, Sandle J, Mirza TA, Li NF, Hart IR. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Gut. 2009;58:271–84.CrossRefPubMed
12.
Zurück zum Zitat Osawa H, Smith CA, Ra YS, Kongkham P, Rutka JT. The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells. Neuro-Oncology. 2009;11:381–93.CrossRefPubMedPubMedCentral Osawa H, Smith CA, Ra YS, Kongkham P, Rutka JT. The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells. Neuro-Oncology. 2009;11:381–93.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Ohtani K, Sakamoto H, Rutherford T, Chen Z, Satoh K, Naftolin F. Ezrin, a membrane–cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett. 1999;147:31–8.CrossRefPubMed Ohtani K, Sakamoto H, Rutherford T, Chen Z, Satoh K, Naftolin F. Ezrin, a membrane–cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett. 1999;147:31–8.CrossRefPubMed
14.
Zurück zum Zitat Martin M, Andreoli C, Sahuquet A, Montcourrier P, Algrain M, Mangeat P. Ezrin Nh2-terminal domain inhibits the cell extension activity of the cooh-terminal domain. J Cell Biol. 1995;128:1081–93.CrossRefPubMed Martin M, Andreoli C, Sahuquet A, Montcourrier P, Algrain M, Mangeat P. Ezrin Nh2-terminal domain inhibits the cell extension activity of the cooh-terminal domain. J Cell Biol. 1995;128:1081–93.CrossRefPubMed
15.
Zurück zum Zitat Li Q, Wu M, Wang H, Xu G, Zhu T, Zhang Y, et al. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells. Cancer Lett. 2008;261:55–63.CrossRefPubMed Li Q, Wu M, Wang H, Xu G, Zhu T, Zhang Y, et al. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells. Cancer Lett. 2008;261:55–63.CrossRefPubMed
16.
Zurück zum Zitat Helander TS, Carpen O, Turunen O, Kovanen PE, Vaheri A, Timonen T. ICAM-2 redistributed by ezrin as a target for killer cells. Nature. 1996;382:265–8.CrossRefPubMed Helander TS, Carpen O, Turunen O, Kovanen PE, Vaheri A, Timonen T. ICAM-2 redistributed by ezrin as a target for killer cells. Nature. 1996;382:265–8.CrossRefPubMed
17.
Zurück zum Zitat Pujuguet P, Maestro LD, Gautreau A, Louvard D, Arpin M. Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell. 2003;14:2181–91.CrossRefPubMedPubMedCentral Pujuguet P, Maestro LD, Gautreau A, Louvard D, Arpin M. Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell. 2003;14:2181–91.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Allenspach EJ, Cullinan P, Tong J, Tang Q, Tesciuba AG, Cannon JL, et al. ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. Immunity. 2001;15:739–50.CrossRefPubMed Allenspach EJ, Cullinan P, Tong J, Tang Q, Tesciuba AG, Cannon JL, et al. ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. Immunity. 2001;15:739–50.CrossRefPubMed
19.
Zurück zum Zitat Mackay DJG, Esch F, Furthmayr H, Hall A. Rho-and Rac-dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin/radixin/moesin proteins. Cell Biol. 1997;138:927–38.CrossRef Mackay DJG, Esch F, Furthmayr H, Hall A. Rho-and Rac-dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin/radixin/moesin proteins. Cell Biol. 1997;138:927–38.CrossRef
20.
Zurück zum Zitat Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science. 2011;331:1553–8.CrossRefPubMed Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science. 2011;331:1553–8.CrossRefPubMed
21.
Zurück zum Zitat William NJ, Glisson BS. Novel strategies for the treatment of small-cell lung carcinoma. Nat Rev Clin Oncol. 2011;8:611–9.CrossRefPubMed William NJ, Glisson BS. Novel strategies for the treatment of small-cell lung carcinoma. Nat Rev Clin Oncol. 2011;8:611–9.CrossRefPubMed
23.
Zurück zum Zitat Bretscher A, Reczek D, Berryman M. Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J Cell Sci. 1997;110:3011–8.PubMed Bretscher A, Reczek D, Berryman M. Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J Cell Sci. 1997;110:3011–8.PubMed
24.
Zurück zum Zitat Chen L, Hughes RA, Baines AJ, Conboy J, Mohandas N, An X. Protein 4.1R regulates cell adhesion, spreading, migration and motility of mouse keratinocytes by modulating surface expression of beta 1 integrin. J Cell Sci. 2011;124:2478–87.CrossRefPubMedPubMedCentral Chen L, Hughes RA, Baines AJ, Conboy J, Mohandas N, An X. Protein 4.1R regulates cell adhesion, spreading, migration and motility of mouse keratinocytes by modulating surface expression of beta 1 integrin. J Cell Sci. 2011;124:2478–87.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med. 2004;10:175–81.CrossRefPubMed Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med. 2004;10:175–81.CrossRefPubMed
26.
Zurück zum Zitat Ren L, Hong SH, Cassavaugh J, Osborne T, Chou AJ, Kim SY, et al. The actin–cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene. 2009;28:792–802.CrossRefPubMed Ren L, Hong SH, Cassavaugh J, Osborne T, Chou AJ, Kim SY, et al. The actin–cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene. 2009;28:792–802.CrossRefPubMed
27.
Zurück zum Zitat Estecha A, Sanchez-Martin L, Puig-Kroeger A, Bartolome RA, Teixido J, Samaniego RL, et al. Moesin orchestrates cortical polarity of melanoma tumour cells to initiate 3D invasion. J Cell Sci. 2009;122:3492–501.CrossRefPubMed Estecha A, Sanchez-Martin L, Puig-Kroeger A, Bartolome RA, Teixido J, Samaniego RL, et al. Moesin orchestrates cortical polarity of melanoma tumour cells to initiate 3D invasion. J Cell Sci. 2009;122:3492–501.CrossRefPubMed
28.
Zurück zum Zitat Tynninen O, Carpen O, Jaaskelainen J, Paavonen T, Paetau A. Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neuro. 2004;30:472–7.CrossRef Tynninen O, Carpen O, Jaaskelainen J, Paavonen T, Paetau A. Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neuro. 2004;30:472–7.CrossRef
29.
Zurück zum Zitat Takeichi M, Watabe M, Shibamoto S, Ito F, Oda H, Uemura T, et al. Dynamic control of cell–cell adhesion for multicellular organization. C R Acad Sci III. 1993;316:818–21. Takeichi M, Watabe M, Shibamoto S, Ito F, Oda H, Uemura T, et al. Dynamic control of cell–cell adhesion for multicellular organization. C R Acad Sci III. 1993;316:818–21.
30.
Zurück zum Zitat Nagafuchi A, Ishihara S, Tsukita S. The roles of catenins in the cadherin-mediated cell adhesion: functional analysis of E-cadherin–alpha catenin fusion molecules. J Biol Chem. 1994;127:235–45. Nagafuchi A, Ishihara S, Tsukita S. The roles of catenins in the cadherin-mediated cell adhesion: functional analysis of E-cadherin–alpha catenin fusion molecules. J Biol Chem. 1994;127:235–45.
31.
Zurück zum Zitat Federici C, Brambilla D, Lozupone F, Matarrese P, de Milito A, Lugini L, et al. Pleiotropic function of ezrin in human metastatic melanomas. Int J Cancer. 2009;124:2804–12.CrossRefPubMed Federici C, Brambilla D, Lozupone F, Matarrese P, de Milito A, Lugini L, et al. Pleiotropic function of ezrin in human metastatic melanomas. Int J Cancer. 2009;124:2804–12.CrossRefPubMed
32.
Zurück zum Zitat Lugini L, Matarrese P, Tinari A, Lozupone F, Federici C, Iessi E, et al. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res. 2006;66:3629–38.CrossRefPubMed Lugini L, Matarrese P, Tinari A, Lozupone F, Federici C, Iessi E, et al. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res. 2006;66:3629–38.CrossRefPubMed
33.
Zurück zum Zitat Brambilla D, Zamboni S, Federici C, Lugini L, Lozupone F, Milito AD, Cecchetti S, Cianfriglia M, Fais S. P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma. Int J Cancer. 2011, doi: 10.1002/ijc.26285. Brambilla D, Zamboni S, Federici C, Lugini L, Lozupone F, Milito AD, Cecchetti S, Cianfriglia M, Fais S. P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma. Int J Cancer. 2011, doi: 10.​1002/​ijc.​26285.​
34.
Zurück zum Zitat Parlato S, Giammarioli AM, Logozzi M, Lozupone F, Matarrese P, Luciani F, et al. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 2000;19:5123–34.CrossRefPubMedPubMedCentral Parlato S, Giammarioli AM, Logozzi M, Lozupone F, Matarrese P, Luciani F, et al. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 2000;19:5123–34.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Brambilla D, Fais S. The Janus-faced role of ezrin in “linking” cells to either normal or metastatic phenotype. Int J Cancer. 2009;125:2239–45.CrossRefPubMed Brambilla D, Fais S. The Janus-faced role of ezrin in “linking” cells to either normal or metastatic phenotype. Int J Cancer. 2009;125:2239–45.CrossRefPubMed
Metadaten
Titel
Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells
verfasst von
Qingchang Li
Hui Gao
Hongtao Xu
Xin Wang
Yongqi Pan
Fengxia Hao
Xueshan Qiu
Maggie Stoecker
Endi Wang
Enhua Wang
Publikationsdatum
01.10.2012
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 5/2012
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-012-0400-9

Weitere Artikel der Ausgabe 5/2012

Tumor Biology 5/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.